Friedreich's ataxia: Idebenone treatment in early stage patients

Neuropediatrics

Volumn 33, Issue 4, 2002, Pages 190-193

  Artuch, Rafael ^a   Aracil, A ^a   Mas, A ^a   Colome C ^a   Rissech, M ^a   Monros E ^a   Pineda, M ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

FRDA Gene; Friedreich's Ataxia; GAA Trinucleotide Repeat; Hypertrophic Cardiomyopathy; Idebenone Treatment

Indexed keywords

FRATAXIN; IDEBENONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FRIEDREICH ATAXIA; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NEUROPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIOXIDANTS; BENZOQUINONES; CEREBELLUM; CHILD; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRIEDREICH ATAXIA; HUMANS; MALE; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 0036694802     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34494     Document Type: Article

References (15)

1. Artuch R, Colomé C, Vilaseca MA, Aracil A, Pineda M. Monitoring of idebenone treatment in patients with Friedreich's ataxia by high-pressure liquid chromatography with electrochemical detection. J Neurosci Meth 2002; 115: 63-66
2. Campuzano V, Montermini L, Moltó MD, Pianese L, Cossée M, Cañizares J et al. Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423 -1427.
3. Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C et al. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci 1976; 3: 279-286
4. Gillis JC, Benfield P, McTavish D. Idebenone. Drugs and Aging 1994; 5: 133-152
5. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981; 104: 589-620
6. Isnard R, Kalotka H, Durr A, Cossee M, Schmitt M, Pousset F et al. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation 1997; 95: 2247-2249
7. Lodi R, CooperJM, Bradley JL, Manners D, Styles P, Taylor DJ et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 1999; 96: 11492-11495
8. Lodi R, Hart PE, Rajagopalan B, Taylor DJ, Crilley JG, Bradley JL et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol 2001; 49: 590-596
9. Monrós E, Moltó MD, Martínez F, Cañizares J, Blanca J, Vílchez JJ et al. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotid repeat. Am J Hum Genet 1997; 61: 101-110
10. Palau F. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review). Int J Mol Med 2001; 7: 581-589
11. Rötig A, Lonlay PD, Chretien D, Foury F, Koenig M, Sidi D et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nature Genet 1997; 17: 215-217
12. Rustin P, Munnich A, Rötig A. Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. Biofactors 1999; 9: 247-251
13. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999; 354: 1300-1301
14. Schöls L, Vorgerd M, Schillings M, Skipka G, Zange J. Idebenone in patients with Friedreich ataxia. Neuroscience Letters 2001; 306: 169 -172
15. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997; 145: 205 - 211